New Albany, OHNCT05357378Now EnrollingIRB Ready

Degenerative Joint Disease Clinical Trial in New Albany, OH

Access cutting-edge degenerative joint disease treatment through this clinical trial at a research site in New Albany. Study-provided care at no cost to qualified participants.

Sponsored by Hip Innovation Technology

Quick Self-Assessment

See if you qualify for this New Albany location

Preparing your pre-screening questions…

Expert Care in New Albany

Access degenerative joint disease specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related degenerative joint disease treatment provided free

Apply for This New Albany Location

Check if you qualify for this degenerative joint disease clinical trial in New Albany, OH

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to New Albany

    Convenient for OH residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit New Albany site if eligible
  4. 4Begin participation

About This Degenerative Joint Disease Study in New Albany

The purpose of this study is to determine if the use of the HIT Reverse Hip Replacement System is safe and effective in patients undergoing total hip replacement. We will determine whether it is safe and effective by comparing it to the control devices.

Sponsor: Hip Innovation Technology

Who Can Participate

Inclusion Criteria

Patient requires primary THA due to NIDJD or any of its composite diagnoses such as osteoarthritis, avascular necrosis, posttraumatic arthritis, slipped capital epiphysis, fracture of the pelvis, and diastrophic variant requiring unilateral primary THA.
Patient is between 50 (inclusive) and 75 (inclusive) years of age at the time of enrollment.
Patient has preoperative medical clearance and is free from or treated for medical conditions that would pose excessive operative risk.
Patient has a signed and dated Informed Consent Form (ICF).
Patient is willing and able to participate in required follow-up visits at the investigational site and to complete study procedures and questionnaires.

Exclusion Criteria

Patient has received earlier THA, hemi-arthroplasty, or fusion in the contralateral hip in the last 24 months.
Patient has received earlier THA, hemi-arthroplasty, or fusion in the contralateral hip more than 24 months ago and has a contralateral hip-specific pain rating of ≥2 on a Numeric Rating Scale 0-10.
Patient needs bilateral hip replacement or has a planned THA on the contralateral hip joint in the next 24 months.
Patient needs knee arthroplasty or has a planned total knee arthroplasty in the next 24 months.
Patient has a known allergy to titanium and/or XLPE.
Patient has known metal sensitivities to cobalt chromium (CoCr).
Patient has a history of septic arthritis in the index joint.
Patient has insufficient acetabular or femoral bone stock in which good anchorage of the implants is unlikely or impossible.
Patient has total or partial absence of the muscular or ligamentous apparatus.
Patient has known moderate to severe renal insufficiency.
Patient has vascular insufficiency, muscular atrophy, or neuromuscular disease in either leg (based on the Investigator's judgment).
Patient has a deformity of the affected limb or significant anatomic variance of the affected hip.
Patient has an active malignancy or history of invasive malignancy within the last 5 years, except for superficial basal cell carcinoma or squamous cell carcinoma of the skin that has been definitively treated. Patients with carcinoma in situ of the uterine cervix definitively treated more than 1 year prior to enrollment may enter the study.
Patient has Paget's disease, Charcot-Marie-Tooth disease, or osteomalacia.
Patient has an inflammatory DJD including any of its composite diagnoses: rheumatoid arthritis, systemic lupus erythematosus, pigmented villonodular synovitis, juvenile rheumatoid arthritis, and other arthritic processes of inflammatory or autoimmune etiology.
Patient has any condition that would interfere with self-assessment of pain, function, or quality of life (QoL) required for patient-reported outcomes during the study (based on the Investigator's judgment).
Patient has a Body Mass Index (BMI) of 40 or higher.
Patient has an active infection (e.g., hepatitis, Acquired Immune Deficiency Syndrome (AIDS), AIDS-related Complex (ARC)) that is systemic or at the site of the intended surgery.
Patient is currently participating in any investigational study not related to this study's preoperative or postoperative care.
Patient is currently pregnant or is planning to become pregnant during the study.
Patient is a competitive or professional athlete.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in New Albany?

Yes, this clinical trial (NCT05357378) has an active research site in New Albany, OH that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Degenerative Joint Disease Treatment Options in New Albany, OH

If you're searching for degenerative joint disease treatment options in New Albany, OH, this clinical trial (NCT05357378) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our New Albany research site is actively enrolling participants for this clinical trial. You'll receive care from experienced degenerative joint disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all degenerative joint disease clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in New Albany, OH

See all rheumatoid arthritis clinical trials recruiting in New Albany — not just this study.

Browse Rheumatoid Arthritis Trials in New Albany →

Browse More Trials by Condition

Rheumatoid Arthritis TrialsAnkylosing Spondylitis TrialsOsteoarthritis TrialsOsteogenesis Imperfecta TrialsAll Conditions →

Ready to Join in New Albany?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · New Albany, OH